Corrigendum to "Prevalence of treatment-related adverse events (TRAEs) with antibody-drug conjugates in metastatic breast cancer patients: A systematic review and meta-analysis" [Crit. Rev. Oncol./Hematol. 204 (2024) 104527]
- PMID: 39510866
- DOI: 10.1016/j.critrevonc.2024.104550
Corrigendum to "Prevalence of treatment-related adverse events (TRAEs) with antibody-drug conjugates in metastatic breast cancer patients: A systematic review and meta-analysis" [Crit. Rev. Oncol./Hematol. 204 (2024) 104527]
Erratum for
-
Prevalence of treatment-related adverse events (TRAEs) with antibody-drug conjugates in metastatic breast cancer patients: A systematic review and meta-analysis.Crit Rev Oncol Hematol. 2024 Dec;204:104527. doi: 10.1016/j.critrevonc.2024.104527. Epub 2024 Oct 10. Crit Rev Oncol Hematol. 2024. PMID: 39395623
Publication types
LinkOut - more resources
Full Text Sources
